Ortho-Clinical Diagnostics launches new troponin I assay:
This article was originally published in Clinica
A diagnostic for heart attacks has been launched by Ortho-Clinical Diagnostics, a subsidiary of Johnson & Johnson. The test detects troponin I, a biomarker for heart damage, in human serum and plasma. It is used with other cardiac tests to help diagnose heart attack and heart injury. It may also be used to predict the risk of having a future coronary event. The Raritan, New Jersey firm says the test is now launched worldwide, but as this is dependent on approval status, the test is currently only available in Europe and the US. Approval applications are pending in Japan, China and other countries.